PIETRANGELO, Antonello
 Distribuzione geografica
Continente #
NA - Nord America 36.292
EU - Europa 18.474
AS - Asia 17.867
SA - Sud America 2.601
AF - Africa 366
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 75.694
Nazione #
US - Stati Uniti d'America 35.607
SG - Singapore 5.263
CN - Cina 4.969
GB - Regno Unito 4.729
IT - Italia 4.236
SE - Svezia 3.394
BR - Brasile 2.039
HK - Hong Kong 1.910
VN - Vietnam 1.773
DE - Germania 1.456
FI - Finlandia 1.246
BD - Bangladesh 936
KR - Corea 863
UA - Ucraina 742
FR - Francia 691
RU - Federazione Russa 611
TR - Turchia 526
IN - India 395
CA - Canada 371
BG - Bulgaria 303
NL - Olanda 277
ID - Indonesia 226
AR - Argentina 201
MX - Messico 163
JP - Giappone 152
IQ - Iraq 141
PL - Polonia 104
ZA - Sudafrica 98
BE - Belgio 92
PK - Pakistan 87
ES - Italia 86
AE - Emirati Arabi Uniti 84
IE - Irlanda 84
CO - Colombia 75
MY - Malesia 73
EC - Ecuador 70
AT - Austria 67
LT - Lituania 64
AU - Australia 63
CL - Cile 60
VE - Venezuela 56
EG - Egitto 52
RO - Romania 50
PH - Filippine 49
CH - Svizzera 40
UZ - Uzbekistan 40
MA - Marocco 39
SA - Arabia Saudita 39
IR - Iran 37
TH - Thailandia 36
DZ - Algeria 34
JM - Giamaica 33
KE - Kenya 30
PY - Paraguay 30
IL - Israele 29
TN - Tunisia 29
CZ - Repubblica Ceca 27
PE - Perù 27
BO - Bolivia 25
JO - Giordania 25
NP - Nepal 24
CR - Costa Rica 23
GR - Grecia 22
OM - Oman 22
PT - Portogallo 20
TW - Taiwan 20
KZ - Kazakistan 19
AZ - Azerbaigian 17
ET - Etiopia 17
HN - Honduras 17
HU - Ungheria 17
SI - Slovenia 17
RS - Serbia 15
UY - Uruguay 14
AL - Albania 13
LB - Libano 13
PS - Palestinian Territory 13
SK - Slovacchia (Repubblica Slovacca) 13
DK - Danimarca 11
SY - Repubblica araba siriana 11
TT - Trinidad e Tobago 11
BY - Bielorussia 10
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
EU - Europa 10
NG - Nigeria 10
PA - Panama 10
KG - Kirghizistan 9
SN - Senegal 9
CY - Cipro 8
GE - Georgia 8
GT - Guatemala 8
KH - Cambogia 8
NI - Nicaragua 8
QA - Qatar 8
XK - ???statistics.table.value.countryCode.XK??? 8
AM - Armenia 7
LV - Lettonia 7
AO - Angola 6
BH - Bahrain 6
Totale 75.563
Città #
Ashburn 3.561
Fairfield 3.380
Southend 3.205
Singapore 3.186
Santa Clara 2.947
Woodbridge 2.261
Hong Kong 1.883
Hefei 1.859
Stockholm 1.817
Houston 1.799
Chandler 1.794
Jacksonville 1.388
San Jose 1.366
Wilmington 1.157
Seattle 1.150
Cambridge 1.051
Ann Arbor 969
Dearborn 969
Helsinki 956
Chicago 939
London 845
Nyköping 828
Seoul 801
Beijing 795
Los Angeles 637
Ho Chi Minh City 598
Modena 545
Council Bluffs 537
The Dalles 478
Hanoi 415
Milan 387
New York 386
Dallas 378
San Diego 374
Princeton 301
Sofia 280
Buffalo 260
Eugene 236
Lauterbourg 231
Berlin 211
Rome 211
São Paulo 205
Izmir 204
Moscow 193
Shanghai 188
Munich 170
Des Moines 159
Jakarta 153
Bologna 150
Redwood City 145
Salt Lake City 144
Frankfurt am Main 115
Orem 107
Phoenix 106
Toronto 102
Tokyo 100
Columbus 99
Amsterdam 90
Bremen 88
Da Nang 88
Warsaw 81
Montreal 80
Falls Church 77
Brussels 72
Reading 72
Parma 71
Boardman 68
Elk Grove Village 68
Philadelphia 68
Porto Alegre 68
Atlanta 67
Dublin 65
Chennai 64
Ottawa 64
Tampa 63
Brooklyn 62
Rio de Janeiro 62
Yalova 60
Haiphong 59
Kent 58
Florence 56
Mexico City 55
San Francisco 55
Baghdad 54
Naples 53
Nuremberg 53
Johannesburg 52
Nanjing 52
Paris 52
Guangzhou 48
Denver 47
Norwalk 47
Belo Horizonte 46
Fremont 45
Turku 45
Bari 44
Brasília 43
Dhaka 43
Miano 43
Miami 42
Totale 52.301
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.837
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 712
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 494
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 486
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 462
Coproporphyrin excretion in healthy newborn babies 457
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 439
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 436
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 427
Non-HFE Hepatic Iron Overload. 424
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 411
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 407
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 403
Hereditary hemochromatosis--a new look at an old disease. 400
Ferroportin disease: Pathogenesis, diagnosis and treatment 400
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 398
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 397
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 397
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 391
Human macrophage ferroportin biology and the basis for the ferroportin disease 391
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 384
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 384
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 382
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 379
ER stress controls iron metabolism through induction of hepcidin. 370
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 365
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 362
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 360
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 360
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 356
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 354
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 354
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 351
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 346
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 344
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 343
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 342
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 341
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 340
Duodenal ferritin synthesis in genetic hemochromatosis 339
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 338
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 338
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 336
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 336
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 336
An unfortunate case of post-ERCP complications 336
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 335
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 335
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 335
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 335
Haptoglobin modifies the hemochromatosis phenotype in mice 331
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 328
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 328
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 327
Heterogeneity of hemochromatosis in Italy 326
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 325
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 323
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 322
Haemochromatosis 322
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 315
DNA repair in lymphocytes from humans and rats with chronic iron overload. 315
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 315
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 313
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 312
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 312
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 311
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 308
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 306
Iron and steatohepatitis. 306
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 305
C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration 304
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 303
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 302
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 302
The impact of inherited thrombophilia on liver transplantation. 301
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 300
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 297
Liver gene expression during chronic dietary iron overload in rats 296
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 295
Missed treatment in an Italian HBV infected patients cohort: HBV RER 295
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 294
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 292
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 292
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 289
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 289
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 288
Antioxidant activity of silybin in vivo during long-term iron overload in rats 287
Disease progression and liver cancer in the ferroportin disease 285
Lack of enterocyte iron accumulation in the ferroportin disease 283
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 282
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 281
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 281
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 280
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 278
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 276
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 272
Huh-7: a human hemochromatotic cell line. 272
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 271
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 271
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 270
Totale 35.663
Categoria #
all - tutte 283.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 283.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/202626.539 1.709 1.253 2.283 2.289 2.710 2.089 3.031 1.244 4.417 2.305 1.654 1.555
2026/2027837 837 0 0 0 0 0 0 0 0 0 0 0
Totale 76.092